Journal profile · Biotechnology & Applied Microbiology
Cytotechnology
ISSN 0920-9069 · eISSN 1573-0778 · Springer Netherlands · NETHERLANDS · Monthly · Founded 1987
Cytotechnology: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 2.2; hybrid open access; APC about USD 4,190; median 90 days to acceptance (105 articles, last 24 months); community-reported acceptance: easy; 188 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cytotechnology is published by Springer Netherlands and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Viral Infectious Diseases and Gene Expression in Insects, 3D Printing in Biomedical Research and Virus-based gene therapy research, together about 32.5% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Cytotechnology is an international journal on the latest developments, methods and techniques in cell culture research involving in vitro systems rather than whole organisms, and the applications of that research in human and veterinary medicine, animal cell biotechnology and cell-based bioassays. The exploitation of cell cultures in a biotechnological context is based upon research generated at all levels of academic and industrial input. The aim of Cytotechnology is to centralize information on both the infrastructure of cell technology and the applied use of cell cultures and thus generate a better understanding of the many facets and disciplines needed to develop successful cell culture processes. The scope of the Journal includes: 1. The derivation, genetic modification and characterization of cell lines, genetic and phenotypic regulation, control of cellular metabolism, cell physiology and biochemistry related to cell function, performance and expression of cell products. 2. Cell culture techniques, substrates, environmental requirements and optimization, cloning, hybridization and molecular biology, including genomic and proteomic tools. 3. Cell culture systems, processes, reactors, scale-up, and industrial production. Descriptions of the design or construction of equipment, media or quality control procedures, that are ancillary to cellular research. 4. The application of animal/human cells in research in the field of stem cell research including maintenance of stemness, differentiation, genetics, and senescence, cancer research, research in immunology, as well as applications in tissue engineering and gene therapy. 5. The use of cell cultures as a substrate for bioassays, biomedical applications and in particular as a replacement for animal models. Cytotechnology publishes original papers, reviews and short communications. The importance of publishing factual reports on techniques, characterization and standardization of cell lines, and presenting updated information on international issues (e.g. import and export regulations, health and safety factors) is recognized by the inclusion of a special section entitled ‘technical reports’. Honorary Editors David W. Barnes, PhD, Georgia Gwinett College, United States of America Niels Bols, PhD, University of Waterloo, Canada J.B. Griffiths, PhD, Centre For Applied Microbiology & Research, United Kingdom Hiroki Murakami, PhD, Kyushu University, Japan Sanetaka Shirahata, PhD, Kyushu University, Japan Raymo
From the journal's Aims & Scope
Research area (LetPub): Biotechnology & Applied Microbiology
Editor-in-chief Francesco De LoguPublisher website
Editorial board by country: 2 in mainland China (about 6%); most named Japan 10, India 5, Italy 5, United States 3, Mainland China 2 (35 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Viral Infectious Diseases and Gene Expression in InsectsBiochemistry, Genetics and Molecular Biology19.4%
- 3D Printing in Biomedical ResearchEngineering6.6%
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology6.6%
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology6.2%
- Mesenchymal stem cell researchMedicine6%
- Monoclonal and Polyclonal Antibodies ResearchMedicine5.3%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EI CompendexEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.2LetPub ·
- Impact factor (publisher) 2025
- 2.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.2Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0.53LetPub ·
- SNIP 2026-06
- 0.58LetPub ·
- h-index
- 52LetPub ·
- h-index
- 94OpenAlex ·
- i10-index
- 1,706OpenAlex ·
- 2-year mean citedness
- 1.57OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 10.1%LetPub ·
Volume
- Articles per year
- 182LetPub ·
- Downloads per year (publisher) 2025
- 328,200Publisher website ·
Articles by year OpenAlex count · 3,533 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 181 | 180 | 28 |
| 2025 | 188 | 186 | 377 |
| 2024 | 79 | 79 | 298 |
| 2023 | 43 | 43 | 273 |
| 2022 | 58 | 58 | 459 |
| 2021 | 62 | 62 | 702 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
90 daysMedian, submission to acceptance · P25–P75 62 days – 148 days
- Acceptance to online
- median 14 days (105 articles)
- Submission to online
- median 102 days
- Sample
- 105 articles with submission and acceptance dates (400 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 22 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,190 / EUR 3,190 / GBP 2,790 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- print version color
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Author–date
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review
- AI use Generative AI Images
LLMs cannot be authors; AI-assisted copy editing need not be declared Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
Competing interests disclosure required Model summary
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
Data availability statement required for all original research Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
Open Choice articles retain copyright with author under Creative Commons license Model summary
To find out more about publishing your work Open Access in Cytotechnology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Reviewer suggestions and exclusions allowed at submission Model summary
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Netherlands
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Monthly
- Founded
- 1987
- ISSN
- 0920-9069
- Electronic ISSN
- 1573-0778
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cytotechnology
What CAS zone is Cytotechnology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cytotechnology is in Zone 4 of Biology, and in Zone 4 of the minor category Biotechnology & Applied Microbiology / Cell Biology. In the 2026 Xinrui edition it is in Zone 4 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cytotechnology?
The latest impact factor listed by LetPub is 2.2; CiteScore 2.3, h-index 94.
How long does peer review take at Cytotechnology?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 90 days (interquartile range 62–148 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cytotechnology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Author–date; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cytotechnology based?
Of the 35 board members whose country the journal's board page names, 2 (about 6%) are in mainland China; the countries named most often are Japan (10), India (5) and Italy (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Cytotechnology?
According to LetPub and DOAJ records, Cytotechnology is indexed in SCIE and Scopus. The journal's website also lists EI Compendex, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Cytotechnology open access, and what is the APC?
Cytotechnology is a hybrid journal. For open-access publication: APC about USD 4,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .